Literature DB >> 6618828

Contrast enhancement pharmacokinetics of six ionic and nonionic contrast media.

P B Dean, L Kivisaari, M Kormano.   

Abstract

The contrast enhancement of six contrast media (CM) was compared in 13 tissues of the rat after rapid intravenous bolus injection. The rats were sacrificed at 0 and 40 seconds and 2, 5, and 15 minutes after contrast injection. 125I labeled diatrizoate, metrizamide, ioxaglate, iohexol, iopamidol, and a nonionic dimer, iodecol, were each injected at a dose of 612 mg iodine per kg body weight, and iodine concentration (IC) and contrast enhancement were calculated from radioactivity measurements. Higher blood IC values were obtained with the nonionic CM; similar enhancement patterns were seen in the spleen, heart, lungs, and brain. Renal IC was directly related to the number of iodine atoms per ion or molecule of CM. In consequence, renal IC was inversely related to the CM osmolality, but no such correlation was seen with the blood IC. Metrizamide produced the greatest IC in the organs of the gastrointestinal tract. There was no apparent correlation of IC with molecular structure of physicochemical parameters of the CM in any of the other tissues studied.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6618828     DOI: 10.1097/00004424-198307000-00015

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  8 in total

1.  Contrast enhancement of brain tumors and irradiated normal brain: a comparison of iohexol and iothalamate.

Authors:  J R Fike; C E Cann; K Turowski; D Norman; L Ax
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

Review 2.  Nanoparticle contrast agents for X-ray imaging applications.

Authors:  Jessica C Hsu; Lenitza M Nieves; Oshra Betzer; Tamar Sadan; Peter B Noël; Rachela Popovtzer; David P Cormode
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-05-22

Review 3.  An overview of the clinical pharmacokinetics of x-ray contrast media.

Authors:  M Bourin; P Jolliet; F Ballereau
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

4.  Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging.

Authors:  James F Hainfeld; Sharif M Ridwan; Yaroslav Stanishevskiy; Nathaniel R Smilowitz; James Davis; Henry M Smilowitz
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

5.  Iodine nanoparticles enhance radiotherapy of intracerebral human glioma in mice and increase efficacy of chemotherapy.

Authors:  James F Hainfeld; Sharif M Ridwan; Yaroslav Stanishevskiy; Rahul Panchal; Daniel N Slatkin; Henry M Smilowitz
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

6.  Arterial attenuation in individualized computed tomography pulmonary angiography injection protocol adjusted based on the patient's body mass index.

Authors:  Leila Jamali; Babak Alikhani; Tobias Getzin; Kristina Imeen Ringe; Frank K Wacker; Hans-Jürgen Raatschen
Journal:  J Res Med Sci       Date:  2020-10-28       Impact factor: 1.852

7.  Iodine nanoparticle radiotherapy of human breast cancer growing in the brains of athymic mice.

Authors:  James F Hainfeld; Sharif M Ridwan; F Yaroslav Stanishevskiy; Henry M Smilowitz
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

8.  Iodine Nanoparticles (Niodx) for Radiotherapy Enhancement of Glioblastoma and Other Cancers: An NCI Nanotechnology Characterization Laboratory Study.

Authors:  James F Hainfeld; Sharif M Ridwan; Yaroslav Stanishevskiy; Henry M Smilowitz
Journal:  Pharmaceutics       Date:  2022-02-25       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.